JRSIS Health Care Corporation

OTCPK:JRSS Stock Report

Market Cap: US$5.2m

JRSIS Health Care Past Earnings Performance

Past criteria checks 0/6

JRSIS Health Care's earnings have been declining at an average annual rate of -41.1%, while the Specialty Retail industry saw earnings growing at 25.2% annually. Revenues have been declining at an average rate of 49.4% per year.

Key information

-41.1%

Earnings growth rate

-38.3%

EPS growth rate

Specialty Retail Industry Growth26.6%
Revenue growth rate-49.4%
Return on equityn/a
Net Margin-2.3%
Last Earnings Update31 Dec 2023

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown
Beta

How JRSIS Health Care makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:JRSS Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 233000
30 Sep 230000
30 Jun 230000
31 Mar 230000
31 Dec 220000
30 Sep 220000
30 Jun 220000
31 Mar 22-7000
31 Dec 210000
30 Sep 2113110
30 Jun 2123220
31 Mar 2137330
31 Dec 2036320
30 Sep 2032020
30 Jun 2029020
31 Mar 2030020
31 Dec 1931120
30 Sep 1931030
30 Jun 1930020
31 Mar 1929120
31 Dec 1828220
30 Sep 1828610
30 Jun 1827510
31 Mar 1825510
31 Dec 1724510
30 Sep 1722410
30 Jun 1720410
31 Mar 1719410
31 Dec 1618310
30 Sep 1617310
30 Jun 1615310
31 Mar 1614210
31 Dec 1512210
30 Sep 1510110
30 Jun 158100
31 Mar 157100
31 Dec 146100
30 Sep 146100
30 Jun 145100
31 Mar 145000
31 Dec 134000

Quality Earnings: JRSS is currently unprofitable.

Growing Profit Margin: JRSS is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: JRSS is unprofitable, and losses have increased over the past 5 years at a rate of 41.1% per year.

Accelerating Growth: Unable to compare JRSS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: JRSS is unprofitable, making it difficult to compare its past year earnings growth to the Specialty Retail industry (-16.3%).


Return on Equity

High ROE: JRSS's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.